Summary
This 8-K filing from CVS Health Corporation (CVS) on November 28, 2018, officially announces the completion of its acquisition of Aetna Inc. The merger, which closed on November 27, 2018, represents a significant transformative event for CVS Health. Aetna shareholders received a combination of CVS Health common stock and cash, totaling approximately $70 billion in aggregate merger consideration. This strategic move is expected to reshape CVS Health's business model and market position. The filing also details the financing of the acquisition, primarily through substantial debt issuance, including various senior notes and term loan borrowings. Additionally, it outlines changes to CVS Health's Board of Directors and the appointment of key leadership roles, including a new employment agreement for Karen Lynch as Executive Vice President and President of Aetna, underscoring the integration efforts and executive planning post-merger. Financial statements and pro forma information related to the acquisition will be filed separately.
Key Highlights
- 1CVS Health has officially completed its acquisition of Aetna Inc. as of November 27, 2018.
- 2The total aggregate merger consideration paid to Aetna shareholders and equity award holders was approximately $70 billion.
- 3Aetna shareholders received a mix of CVS Health common stock (0.8378 shares) and cash ($145.00) per Aetna share.
- 4The acquisition was financed through significant debt issuances, including multiple tranches of Senior Notes and term loan borrowings, totaling billions of dollars.
- 5Four new directors were appointed to the CVS Health Board of Directors effective upon the merger completion.
- 6Karen S. Lynch has entered into an amended employment agreement to serve as Executive Vice President, CVS Health and President, Aetna.
- 7Detailed financial statements and pro forma financial information for the acquired Aetna business will be filed in an amendment to this 8-K at a later date.